IKS Health Acquires TruBridge for $26.25 per Share

IKS Health enters definitive agreement to acquire TruBridge for $26.25 per share in cash, valuing the transaction by TruBridge's outstanding shares.
Acquisition combines IKS's AI-driven care enablement with TruBridge's rural healthcare technology, serving 2,000+ organizations and 150,000+ clinicians.
Transaction expected to close Q3 2026, financed through new debt from Citibank, JPMorganChase, and Deutsche Bank, pending shareholder and regulatory approvals.
TruBridge's largest shareholders controlling 27% of shares have agreed to vote in favor of the transaction through voting support agreements.